Cstone pharma aktie
WebJun 7, 2024 · CStone Pharmaceuticals (OTCPK:CSPHF) (2616.HK) revenue fell 77% last year and its net loss climbed, as the Chinese drug company saw one-off license fees decline sharply and marketing costs to ...
Cstone pharma aktie
Did you know?
WebPipeline-CStone Pharmaceuticals. We focus on immuno-oncology and precision medicine with a well-balanced oncology portfolio of 15 innovative assets. Currently, CStone has received 10 NDA approvals for its 4 … WebMar 13, 2024 · Their share performances varied on Monday, with Broncus Holding Corporation advancing 4% while CStone Pharmaceuticals was down 2.2%. Further supporting sentiment, China reported unexpectedly strong credit growth for February, with money supply expanding at the fastest pace in nearly 7 years, as Beijing looked to …
WebApr 12, 2024 · SUWANEE, Ga., April 12, 2024 /PRNewswire/ -- Inara Patton (DO '26), who emigrated from Russia to America in 2011, is a registered cardiovascular invasive … WebApr 23, 2024 · CStone Pharmaceuticals (HKEX: 2616) is a biopharmaceutical company focused on developing and commercializing innovative immuno-oncology and precision medicines to address the unmet medical needs ...
WebFeb 24, 2024 · CStone Pharmaceuticals is a China-based investment holding company. Through its subsidiaries, the Company is primarily engaged in development, manufacturing and sales of biopharmaceutical products. Its main products include immuno-oncology drugs and molecularly targeted drugs. The Company conducts its businesses mainly in … WebApr 6, 2024 · CStone Pharmaceuticals Announces NMPA Accepts the Supplemental Biologics License Application for Sugemalimab as First-Line Treatment for Esophageal Squamous Cell Carcinoma CI Summary
WebOct 12, 2024 · CStone Pharmaceuticals. Oct 11, 2024, 20:05 ET. SUZHOU, China, Oct. 11, 2024 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616) …
WebCSTONE PHARMACEUTICALS REGISTERED AKTIE Profil - hier finden Sie alle Informationen über CSTONE PHARMACEUTICALS REGISTERED AKTIE wie z.B. Management, Profil, Aktionärsstruktur und Bilanzdaten. the pagemaster vhs coverWebMar 31, 2024 · CStone Pharmaceuticals (HKEX: 2616) is a biopharmaceutical company focused on developing and commercializing innovative immuno-oncology and precision medicines to address the unmet medical needs ... shut or closeWebCStone Pharmaceuticals Aktie 20 Jahre Umsatz, Dividende, Realtime-Kurs, EBIT, Gewinn, Ausschüttungsquote, Nettoverschuldung und die besten Aktienanalysen. ... CStone Pharmaceuticals schüttet eine Dividende von NaN über undefined Auschüttungen im … shu to scovilleWebMar 23, 2024 · 20.03. 13.03. CStone Pharmaceuticals ist eine in China ansässige Investment-Holding. Über seine Tochtergesellschaften ist das Unternehmen … the pagemaster vhs closingWebSuzhou, China, March 20th, 2024--CStone Pharmaceuticals (HKEX: 2616), a leading biopharmaceutical company focused on the research, development, and commercialization of innovative immuno-oncology ther... 15 2024-03. CStone Pharmaceuticals Reports 2024 Annual Results and Business Updates . shuto sports clubWebNov 21, 2024 · CStone Pharmaceuticals (HKEX: 2616) is a biopharmaceutical company focused on researching, developing, and commercializing innovative immuno-oncology and precision medicines to address the unmet medical needs of cancer patients in China and worldwide. Established in 2015, CStone has assembled a world-class management … the pagemaster vhs archiveWebApr 12, 2024 · Damit ist die CStone Pharmaceuticals Aktie (A2PEFW) in 24 Stunden um +9,18 % gestiegen. Auf 7 Tage gesehen hat sich der Kurs der CStone Pharmaceuticals … the pagemaster voice